endothelin-1 has been researched along with Cystadenocarcinoma--Serous* in 3 studies
3 other study(ies) available for endothelin-1 and Cystadenocarcinoma--Serous
| Article | Year |
|---|---|
Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer.
Topics: beta-Arrestin 1; Cell Line, Tumor; Cystadenocarcinoma, Serous; Endothelin-1; Extracellular Matrix; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Podosomes; Proteolysis; ras GTPase-Activating Proteins; Receptor, Endothelin A; Signal Transduction; Vinculin | 2019 |
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; beta-Arrestin 1; Cell Line, Tumor; Cell Survival; Cystadenocarcinoma, Serous; Disease Models, Animal; Endothelin-1; Female; Gene Expression Regulation, Neoplastic; Guanine Nucleotide Exchange Factors; Humans; Mice, Nude; Mutation; Ovarian Neoplasms; Protein Serine-Threonine Kinases; Pyrimidines; Receptor, Endothelin A; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Signal Transduction; Sulfonamides; Transcription Factors; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays; YAP-Signaling Proteins | 2019 |
hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
Topics: Animals; beta-Arrestin 1; Cystadenocarcinoma, Serous; Cytoskeleton; Endothelin A Receptor Antagonists; Endothelin-1; Female; Gene Expression Regulation, Neoplastic; Humans; Mice, Nude; Microfilament Proteins; Ovarian Neoplasms; Podosomes; Pyrimidines; Receptor, Endothelin A; rhoC GTP-Binding Protein; Sulfonamides; Xenograft Model Antitumor Assays | 2018 |